Arcadia BiosciencesRKDA
13F holders, Q1 2026 (March 31)15holders +2
3new positions
3sold out
$1.38avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, up 2 from Q4 2025. 3 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($220K), Sabby Management, LLC ($158K) and Geode Capital Management, LLC ($44K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $395K |
| Exits | 3 | $174 |
All 13F filers, Q4 2025 → Q1 2026: 310,352 shares bought and 88 shares sold, net +310,264 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Armistice Capital, LLC | 0.01% | New | 159,390 | $220K |
| Sabby Management, LLC | 2.99% | New | 114,554 | $158K |
| Geode Capital Management, LLC | 0.00% | Add +197.9% | 31,743 | $44K |
| Susquehanna International Group, LLP | 0.00% | New | 12,614 | $17K |
| State Street Corp. | 0.00% | No change | 12,146 | $17K |
| Vanguard Capital Management LLC | 0.00% | — | 9,644 | $13K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 4,394 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +166.9% | 3,940 | $5K |
| UBS Group AG | 0.00% | Add +42.8% | 807 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 120 | $166 |
| Group One Trading LLC | 0.00% | No change | 18 | $25 |
| Assetmark, Inc. | 0.00% | No change | 5 | $7 |
| Morgan Stanley | 0.00% | No change | 2 | $3 |
| Southern Michigan Bank & Trust | 0.00% | — | 2 | $3 |
| Citigroup Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.